Lv13
48 积分 2025-01-07 加入
Current status of Liraglutide delivery systems for the management of type 2 diabetes mellitus
4小时前
已完结
FDA approval of GLP-1 receptor agonist (liraglutide) for use in children
1天前
已完结
A Validated, Stability-Indicating HPLC Method for the Simultaneous Determination of Five Related Substances in Liraglutide Drug Substance
1天前
已完结
Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions
2天前
已完结
Effect of PLGA raw materials on in vitro and in vivo performance of drug-loaded microspheres PLGA
2个月前
已完结
Influence of Hydrophobic Ion Pairing on Formulation Performance of Liraglutide in PLGA Microspheres
2个月前
已完结
Improvement of liraglutide release from PLGA microspheres by a porous microsphere-gel composite system
2个月前
已完结
Preparation and in vitro/in vivo evaluation of uniform-sized Goserelin-loaded sustained release microspheres
2个月前
已完结
A review of recent research and development on GLP-1 receptor agonists-sustained-release microspheres
2个月前
已完结
Development of 1 Month Sustained-Release Microspheres Containing Liraglutide for Type 2 Diabetes Treatment
2个月前
已完结
皖公网安备34019202002308
